Clinical Trial Update: 3D1015 Injection for Patients With mCRPC [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating 3D1015 Injection in patients with metastatic castration-resistant prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• 3D1015

Snippet

Sponsor: Chunjing Yu | Conditions: Metastatic Castration-resistant Prostate Cancer, mCRPC | Phase 1 | Status: RECRUITING